| Ganetespib studied in …STUDIED_INderived31 of 31show fewer |
|---|
| → studied in | NCT01042379Phase 2 · recruiting I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer · 31 trials list this drug (1 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm,Early Stage Breast Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01560416Phase 2 · completed Fulvestrant With or Without Ganetespib in HR+ Breast Cancer · 31 trials list this drug (1 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03783949Phase 2 · completed European Trial on Enhanced DNA Repair Inhibition in Ovarian Cancer · 31 trials list this drug (1 active) | — | — | Primary Peritoneal Carcinoma,Malignant Fallopian Tube Neoplasm,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01962948Phase 1/Phase 2 · terminated Paclitaxel and Ganetespib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · 31 trials list this drug (1 active) | — | — | Malignant Fallopian Tube Neoplasm,Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01167114Phase 2 · completed STA-9090 in Previously Treated Patients With Advanced Esophagogastric Cancer · 31 trials list this drug (1 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01590160Phase 1/Phase 2 · completed Ganetespib With Platinum, in Patients With Malignant Pleural Mesothelioma · 31 trials list this drug (1 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02012192Phase 1/Phase 2 · terminated GANNET53: Ganetespib in Metastatic, p53-mutant, Platinum-resistant Ovarian Cancer · 31 trials list this drug (1 active) | — | — | Malignant Fallopian Tube Neoplasm,Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02389751Phase 1 · completed Ganetespib in Combination With Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-III Esophageal Cancer · 31 trials list this drug (1 active) | — | — | Malignant Esophageal Neoplasm,Gastroesophageal Junction Adenocarcinoma,Malignant Neoplasm of the Cervical Esophagus+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02008877Phase 1/Phase 2 · completed SARC023: Ganetespib and Sirolimus in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors) · 31 trials list this drug (1 active) | — | — | Sarcoma,Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01173523Phase 2 · completed Study of Hsp90 Inhibitor, STA-9090 for Relapsed or Refractory Small Cell Lung Cancer · 31 trials list this drug (1 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01200238Phase 2 · completed STA-9090(Ganetespib) in Metastatic Ocular Melanoma · 31 trials list this drug (1 active) | — | — | Ocular Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01270880Phase 2 · completed Hsp90 Inhibitor STA-9090 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy · 31 trials list this drug (1 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02060253Phase 1 · completed Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer · 31 trials list this drug (1 active) | — | — | Malignant Breast Neoplasm,Male Breast Carcinoma,HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01665937Phase 1 · completed STA-9090 in Patients With Advanced Hepatocellular Cancer · 31 trials list this drug (1 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02261805Phase 1/Phase 2 · terminated A Phase I/II Study of Ganetespib in Combination With Doxorubicin · 31 trials list this drug (1 active) | — | — | Malignant Neoplasm,Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02192541Phase 1 · terminated Ganetespib and Ziv-Aflibercept in Refractory Gastrointestinal Carcinomas, Non-Squamous Non-Small Cell Lung Carcinomas, Urothelial Carcinomas, and Sarcomas · 31 trials list this drug (1 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01551693Phase 2 · terminated STA-9090(Ganetespib) in Patients With Unresectable Stage III or Stage IV Melanoma · 31 trials list this drug (1 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02334319Phase 1 · terminated Ganetespib Window of Opportunity Study in Head and Neck Cancers · 31 trials list this drug (1 active) | — | — | Laryngeal Squamous Cell Carcinoma,Oral Cavity Squamous Cell Carcinoma,Hypopharyngeal Squamous Cell Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01798485Phase 3 · terminated A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC · 31 trials list this drug (1 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02637375NA · withdrawn A Pilot Preoperative Trial of Ganetespib With Paclitaxel for Triple-Negative Breast Cancer · 31 trials list this drug (1 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01039519Phase 2 · completed A Study Evaluating STA-9090 in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor (GIST) · 31 trials list this drug (1 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01111838Phase 2 · completed Clinical and Translational Study of STA-9090 · 31 trials list this drug (1 active) | — | — | Malignant Colon Neoplasm,Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01273896Phase 2 · completed Open-label Study of STA-9090 for Patients With Metastatic Breast Cancer · 31 trials list this drug (1 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01677455Phase 2 · completed An Open-Label Multicenter Phase 2 Window of Opportunity Study Evaluating Ganetespib in Women With Breast Cancer · 31 trials list this drug (1 active) | — | — | Malignant Breast Neoplasm,Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01485835Phase 1 · completed A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma · 31 trials list this drug (1 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01368003Phase 2 · withdrawn STA-9090 in Castration-Resistant Prostate Cancer With Assessment of Androgen Receptor Pathway Signaling · 31 trials list this drug (1 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01562015Phase 2 · completed A Study of Ganetespib in Subjects With ALK-Positive Non-Small-Cell Lung Cancer (NSCLC) · 31 trials list this drug (1 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01031225Phase 2 · completed A Study of the HSP90 Inhibitor, STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC) · 31 trials list this drug (1 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00687934Phase 1 · completed Study of STA-9090, Administered Once-Weekly in Patients With Solid Tumors · 31 trials list this drug (1 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01227018Phase 2 · terminated PhII Study STA-9090 as Second or Third-Line Therapy for Metastatic Pancreas Cancer · 31 trials list this drug (1 active) | — | — | Malignant Pancreatic Neoplasm,Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01236144Phase 1/Phase 2 · completed A Trial to Establish the Feasibility of Combining Either the Tyrosine Kinase Inhibitor AC220,CXCR4 Inhibitor Plerixafor or HSP90 Inhibitor Ganetespib With Chemotherapy in Older Patients With Acute Myeloid Leukaemia and High Risk Myelodysplastic Syndrome. · 31 trials list this drug (1 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |